{"id":348960,"date":"2021-10-05T22:49:53","date_gmt":"2021-10-05T19:49:53","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/pfizer-vax-is-90-effective-against-severe-covid-19-variants\/"},"modified":"2021-10-05T22:49:53","modified_gmt":"2021-10-05T19:49:53","slug":"pfizer-vax-is-90-effective-against-severe-covid-19-variants","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/pfizer-vax-is-90-effective-against-severe-covid-19-variants\/","title":{"rendered":"#Pfizer vax is 90% effective against severe COVID-19 variants"},"content":{"rendered":"<p>&#8220;<strong>#Pfizer vax is 90% effective against severe COVID-19 variants<\/strong>&#8221;<\/p>\n<div>\n<aside class=\"single__inline-module alignleft\">\n        <\/aside>\n<p>Here\u2019s even more definitive evidence that vaccines save lives.<\/p>\n<p>A new study of more than 3.4 million Pfizer jab recipients has confirmed that vaccination is 90% effective against severe COVID-19 illness for at least six months after the second dose.<\/p>\n<p>It\u2019s the latest Pfizer-backed analysis of their remedy, <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02183-8\/fulltext#cestitle170\">published <\/a>Monday in the Lancet medical journal and conducted by researchers with Kaiser Permanente Southern California. Their findings support preliminary studies of Pfizer\u2019s success, including one shared last spring that also showed six months of protection against severe symptoms based on just 12,000 vaccine recipients. <\/p>\n<p>The ability of the Pfizer-BioNTech vaccine to shield against infection fell by nearly half \u2014 from 88% at one month following the second dose, down to 47% \u2014 after six months. However, despite the shot\u2019s declining defenses against viral transmission, it remained still an average of 90% effective against hospitalizations due to COVID-19, including the more aggressive Delta variant of 2021.<\/p>\n<figure id=\"attachment_19704966\" class=\"wp-caption alignnone aligncenter\"><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-19704966 size-large\" src=\"https:\/\/nypost.com\/wp-content\/uploads\/sites\/2\/2021\/10\/moderna-083.jpg?quality=90&amp;strip=all&amp;w=1024\" alt=\"Pfizer vaccine\" width=\"1024\" height=\"682\" srcset=\"https:\/\/nypost.com\/wp-content\/uploads\/sites\/2\/2021\/10\/moderna-083.jpg?quality=90&amp;strip=all&amp;w=1535 1536w, https:\/\/nypost.com\/wp-content\/uploads\/sites\/2\/2021\/10\/moderna-083.jpg?quality=90&amp;strip=all 1024w, https:\/\/nypost.com\/wp-content\/uploads\/sites\/2\/2021\/10\/moderna-083.jpg?quality=90&amp;strip=all&amp;w=512 512w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\"\/><figcaption class=\"wp-caption-text\"><span>Two doses of the Pfizer-BioNTech vaccine remains about 90% effective against all COVID-19 variants for at least six months after inoculation, according to a new study of 3.4 million vaccine recipients.<\/span><span class=\"credit\">LightRocket via Getty Images<\/span><\/figcaption><\/figure>\n<p>During the study period, between December 2020 and August 2021, just 5.4% reported breakthrough infections. And only a fraction of that group \u2014 6.6% \u2014 ended up in the hospital with COVID-19 despite vaccination.<\/p>\n<figure class=\"wp-block-pullquote alignright\">\n<blockquote><p>\u2018Considerations for booster shots should take global COVID-19 vaccine supply into account as people in many countries around the world have not yet received a primary vaccination <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/watch-movies-tv-seriess\/\" data-internallinksmanager029f6b8e52c=\"8\" title=\"Watch Movies &amp; TV Series\" target=\"_blank\" rel=\"noopener\">series<\/a>.\u2019<\/p>\n<p><cite>Dr. Sara Tartof, researcher at Kaiser Permanente Southern California<\/cite><\/p><\/blockquote>\n<\/figure>\n<p>\u201cOur study confirms that vaccines are a critical tool for controlling the pandemic and remain highly effective in preventing severe disease and hospitalization, including from the Delta and other variants of concern. Protection against infection does decline in the months following a second dose,\u201d said the study\u2019s lead author Dr. Sara Tartof in a statement, <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.upi.com\/Health_News\/2021\/10\/05\/covid19-vaccine-pfizer-efficacy-six-months\/9841633438749\/\">reported HealthDay<\/a>.<\/p>\n<p>She continued, \u201cWhile this study provides evidence that immunity wanes for all age groups that received the vaccine, the [US Centers for Disease Control and Prevention] Advisory Committee on Immunization Practices has called for additional research to determine if booster shots should be made available to all age groups eligible for this vaccine.\u201d<\/p>\n<p>The <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/news\/\" data-internallinksmanager029f6b8e52c=\"2\" title=\"News\" target=\"_blank\" rel=\"noopener\">news<\/a> comes as health agencies continue to mull the decision of whether and when to make booster vaccines, from Pfizer, Moderna or Johnson &amp; Johnson, available to the wider public \u2014 as they now do for those aged 65 years and up; living with comorbidities at any age; or workers in select essential and front-line industries. At the same time, public service agencies, private corporations and small businesses have begun setting vaccine mandates for their workforces, leaving some of those without defense against COVID-19 on unemployment. <\/p>\n<aside class=\"single__inline-module alignleft\">\n    <\/aside>\n<p>To that end, Tartof urged US health officials to consider equity in the global fight against COVID-19.<\/p>\n<p>\u201cIn line with the recent [US Food and Drug Administration] and CDC recommendations, considerations for booster shots should take global COVID-19 vaccine supply into account as people in many countries around the world have not yet received a primary vaccination series,\u201d Tartof added.<\/p>\n<p>As the vaccine\u2019s effectiveness decreases, BioNTech has suggested that an entirely new vaccine formula may be required as soon as next year.<\/p>\n<p>BioNTech co-founder and CEO Dr. Ugur Sahin warned last month <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.ft.com\/content\/d88457da-6bbc-4f07-82a6-4738aa845492\">in the Financial Times<\/a>, \u201cThis virus will stay, and the virus will further adapt. We have no reason to assume that the next-generation virus will be easier to handle for the immune system than the existing generation. This is a continuous evolution, and that evolution has just started.\u201d\n                        <\/div>\n<blockquote><p><strong><span style=\"color: #ff6600;\">If you liked the article, do not forget to share it with your friends. Follow us on\u00a0<span style=\"color: #ff0000;\"><a style=\"color: #ff0000;\" href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMLG0nwswvr63Aw\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\">For forums sites go to <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/forum.buradabiliyorum.com\/\" target=\"_blank\" rel=\"noopener\">Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong>\n<\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more News articles, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/en.buradabiliyorum.com\/news\/\" target=\"_blank\" rel=\"noopener\">News category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"https:\/\/nypost.com\/2021\/10\/05\/pfizer-vax-is-90-effective-against-severe-covid-19-variants\/\" target=\"_blank\" rel=\"noopener\">Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;#Pfizer vax is 90% effective against severe COVID-19 variants&#8221; Here\u2019s even more definitive evidence that vaccines save lives. A new study of more than 3.4 million Pfizer jab recipients has confirmed that vaccination is 90% effective against severe COVID-19 illness for at least six months after the second dose. It\u2019s the latest Pfizer-backed analysis of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":348961,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/nypost.com\/wp-content\/uploads\/sites\/2\/2021\/10\/moderna-083.jpg?quality=90&strip=all&w=1024","fifu_image_alt":"","footnotes":""},"categories":[70897],"tags":[117067,1545,82862,74138],"class_list":["post-348960","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-10-5-21","tag-coronavirus","tag-covid-vaccine","tag-pfizer"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/348960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=348960"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/348960\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/348961"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=348960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=348960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=348960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}